TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.

Acta Oncol · 2014 · PMC4245178 · PMID 24909504

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

TP53 mutations were associated with a borderline significant decline in RFS, and a significant decline in OS after FUMI treatment ( Figure 3E, F ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.